Apax Partners announces sale of Mölnlycke Health Care to Investor AB
26 January 2007
London, UK, 26 January 2007. Funds advised by Apax
Partners (Apax), one of the world's leading private equity firms,
announce the sale of Mölnlycke Health Care Group (MHCG) to Investor
AB and Morgan Stanley Principal Investments (MSPI) for €2.85
bn.
Apax Partners used its expertise in the healthcare sector to
identify a buy-and-build opportunity and create a European leader
in the global medical products space.
Ian Jones, partner and head of the healthcare team at Apax,
said: "This has been a very successful deal for all involved and
exemplifies the Apax Partners strategy. Our knowledge of the
healthcare sector allowed us to identify a consolidation
opportunity in the consumable medical products area, and we are
proud to have helped create this unique group. The success of the
strategy is due to the hard work and dedication of the management
team and employees, and the company is now a global leader in its
space."
John Samuel, CEO of MHCG commented: "This is a great outcome for
all concerned. Apax has helped create a strong company poised for
significant growth. Investor AB is a long term partner committed to
supporting our aspirations, and the management and employees are
looking forward to an exciting future. We will continue the
progress we have already made in creating a world class medical
products company."
In 2003, the Apax healthcare team identified a strong fit
between the wound care and surgical businesses owned by SSL
International Plc and the wound care and surgical businesses that
made up Mölnlycke.
Following extensive negotiations, Apax Partners acquired the
wound care division of SSL International (later re-named Medlock
Medical) in March 2004 and the surgical gloves unit (Regent
Medical) in June 2004.
This positioned Apax well for the subsequent auction of
Mölnlycke, which was acquired in June 2005. The three businesses
were then merged in August 2005 to form MHCG.
Apax Partners has subsequently been instrumental in helping
management drive value in the combined group by assisting
post-merger integration, supporting new product development and
strengthening the management team.

Notes to Editors
About Apax Partners
Apax Partners is one of the world's leading private equity
investment groups. It operates across the United States,
Europe, Israel and Asia and has more than 30 years of investing
experience. Funds under the advice of Apax Partners total $20
billion around the world. These Funds provide long-term equity
financing to build and strengthen world-class companies. Apax
Partners Funds invest in companies across its global sectors of
Tech & Telecom, Retail & Consumer, Media, Healthcare and
Financial & Business Services.
About Mölnlycke Health Care Group
Mölnlycke Health Care Group ("MHCG") is a leading global
medical products company which manufactures and markets single-use
wound care and surgical products for the professional health care
sector. MHCG holds a top three market position in the European
advanced wound care market and is the #1 European single-use
surgical products provider. MHCG has established production
facilities in Asia and Europe, and sells into Europe and North
America.
For further information, please contact:
Ben Harding
T: +44 20 7872 6300
E: ben.harding@apax.com